LabConnect Appoints Bill Finger as Senior Vice President, Global Strategic Services
JOHNSON CITY, Tenn., Sept. 19, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Bill Finger as Senior Vice President, Global Strategic Services, effective Wednesday, September 10, 2025. Bill brings more than 25 years of diagnostics and clinical research experience, with deep expertise in the global lab and pharmacy industry. As a senior executive, he...
QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025
Patients who received zovaglutide at a once-monthly dose of 160 mg experienced a 13.8% reduction in body weight at 24 weeks, highly comparable to reductions observed in patients who received 80 mg every other week (12.5%) The overall safety and tolerability of zovaglutide were consistent and comparable with the GLP-1 receptor agonist class of obesity management drugs...
NYSE Content Advisory: Pre-Market Update + Fed cuts interest rates by 0.25%
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Fed cuts interest rates by 0.25%...
Grace Lu rejoining Russell Reynolds Associates Singapore as Managing Director for Healthcare Practice
SINGAPORE, Sept. 18, 2025 /PRNewswire/ -- Russell Reynolds Associates (RRA), the leading global leadership advisory firm, is pleased to announce that Grace Lu is rejoining the Singapore office as a senior member of the Healthcare Practice. Previously based in Beijing, Grace returns to Singapore to lead the firm's Healthcare Practice across Asia Pacific,...
Innovent’s Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2)
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, today announced that the company's partner Ollin reported a clinical update on IBI324 (Ollin R&D code: OLN324). IBI324 (OLN324)...
Investing in Futures: Education Cannot Wait Reaches 14 Million Children in Crises Worldwide
New ECW Results Report highlights transformative education outcomes for children and adolescents in emergencies and protracted crises and calls for urgent funding to sustain progress. NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Education Cannot Wait (ECW), the global fund for education in emergencies and protracted crises in the United Nations, today launched its Investing in Futures: 2024 Annual Results Report...
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway
Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 18, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings from the Phase 3 ALSummit trial of Neuronata-R® (lenzumestrocel), an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral sclerosis...
Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting
YANTAI, China, Sept. 18, 2025 /PRNewswire/ -- RemeGen (688331.SH/09995.HK) announced that the 48-week open-label extension (OLE) data from China Phase III clinical study of telitacicept (RC18, brand name: 泰爱®, a BLyS/APRIL dual-target fusion protein innovative drug independently developed by RemeGen) for the treatment of generalized myasthenia gravis (gMG) was selected as an...
Sunway Medical Centre named Top Malaysian Smart Hospital in Newsweek’s World’s Best Smart Hospitals 2026 ranking
SUNWAY CITY, Malaysia, Sept. 18, 2025 /PRNewswire/ -- Sunway Medical Centre, Sunway City (SMC) has been honoured as top Malaysian hospital and debuted in the top 350 hospitals in the world, as per the latest Newsweek's World's Best Smart Hospitals 2026 ranking. Overview of Sunway Medical Centre, Sunway City. This is the first...
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
SHANGHAI, Sept. 18, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the updated long-term follow-up results of Phase I clinical trial of zevorcabtagene autoleucel (zevor-cel, R&D code: CT053, an autologous CAR T-cell product targeting BCMA) have been presented as...
